Class denied for brand loyalty
A federal judge on Tuesday said that lawyers representing the buyers of two cancer drugs must sort out which buyers would not have switched to a generic version of the medication because of brand loyalty before she would grant those plaintiffs class certification.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10